KanonCure

Yonago, Japan

KanonCure is a manufacturing company that develops and markets regenerative medicine products and pharmaceuticals for digestive disorders.

$4.6M raised

Aug 2021

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has KanonCure raised?

KanonCure has raised $4.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2021.

Who are KanonCure's investors?

KanonCure's investors include CEJ Capital, Green Core, JR West Innovations, Cyberdyne, Yonago Shinkin Bank.

Where is KanonCure headquartered?

KanonCure is headquartered in Yonago, Japan.

What does KanonCure do?

KanonCure is a manufacturing company that develops and markets regenerative medicine products and pharmaceuticals for digestive disorders.

What stage is KanonCure at?

KanonCure is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 5, 2021.

MLA

"KanonCure — Funding & Investors." VCBacked, August 5, 2021, https://www.vcbacked.co/company/kanoncure. Accessed July 3, 2026.

APA

VCBacked. (2021). KanonCure — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/kanoncure

Wikipedia (cite web)

{{cite web |title=KanonCure — Funding & Investors |url=https://www.vcbacked.co/company/kanoncure |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 5, 2021.